newsfilter
← Latest News
GlobeNewswire·

VBL Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

Conference Call and Webcast at 8:30 a.m. EDT Today OVAL Phase 3 registration-enabling study investigating VB-111 in patients with platinum-resistant ovarian cancer remains on track in spite of COVID-19, with over 260 patients enrolled; next DSMC revi